GSK: quarterly results beat expectations
(CercleFinance.com) - GSK, the UK's largest pharmaceutical company, reported higher quarterly results on Wednesday, mainly driven by its vaccine business.
Q2 sales rose 6% year-on-year to 8.1 billion pounds, led by 39% growth in vaccines. Underlying adjusted EPS - the profitability indicator most closely followed by analysts - increased by 46% to 28.1 pence.
These figures beat the consensus, which expected quarterly sales of 7.5 billion pounds and underlying EPS of 20 pence.
The company expects this momentum to continue in the second half of the year.
Even so, the share is currently down 0.8% in London after these announcements
Copyright (c) 2021 CercleFinance.com. All rights reserved.